Yahoo Web Search

Search results

1. People also ask

   How much is immunitybio (IBRX) stock price per share?

   • (NASDAQ: IBRX) Immunitybio stock price per share is $6.24 today (as of Jun 10, 2024). What is Immunitybio's Market Cap? ( NASDAQ: IBRX) Immunitybio 's market cap is $4.32B, as of Jun 11, 2024. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

   Immunitybio Stock Price Today (NASDAQ: IBRX) Quote ... - WallStreetZ…

   www.wallstreetzen.com/stocks/us/nasdaq/ibrx

   See all results for this question

   What is immunitybio (IBRX) market cap?

   • ( NASDAQ: IBRX) Immunitybio 's market cap is $4.32B, as of Jun 11, 2024. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Immunitybio 's market cap is calculated by multiplying IBRX 's current stock price of $6.24 by IBRX 's total outstanding shares of 691,567,961.

   Immunitybio Stock Price Today (NASDAQ: IBRX) Quote ... - WallStreetZ…

   www.wallstreetzen.com/stocks/us/nasdaq/ibrx

   See all results for this question

   Is IBRX a good investment?

   • Financially, IBRX secured a $300M RIPA, enhancing liquidity but imposing sales-based repayments and operational restrictions. Market sentiment is mixed, with significant short interest but growing institutional confidence, indicating volatility and potential resilience. Investors should approach with caution.

   ImmunityBio: Financial And Regulatory Risks Outweigh Anktiva's Promise

   seekingalpha.com/article/4673686-immunitybio-stock-financial-regulatory-risks-outweigh-anktiva-promise

   See all results for this question

   Is IBRX (IBRX) undervalued?

   • IBRX ($6.24) is not significantly undervalued (594.9%) relative to our estimate of its Fair Value price of -$1.26 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety Significantly Below Fair Value Valuation IBRX is unprofitable, so we... subscribe to Premium to read more.

   Immunitybio Stock Price Today (NASDAQ: IBRX) Quote ... - WallStreetZ…

   www.wallstreetzen.com/stocks/us/nasdaq/ibrx

   See all results for this question

2. finance.yahoo.com › quote › IBRXImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History ...

   finance.yahoo.com › quote › IBRX

   • Cached

   ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases.

   • Conversations

     Find the latest ImmunityBio, Inc. (IBRX) stock discussion in...

   • Analysis

     See ImmunityBio, Inc. (IBRX) stock analyst estimates,...

3. ImmunityBio, Inc.

   NasdaqGS: IBRX

   6.63

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.40 (+6.43%)

   As of Thu. Jun 20, 2024 1:51 PM EDT · Nasdaq Real Time Price (USD) · Market open

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	6.36
     High	7.37
     Low	6.33

   • Mkt Cap	4.59B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	6.23
     52 Wk. Low	1.25
     52 Wk. High	10.53

   More about IBRX

   Related stocks

   • IOVA
     Iovance Biotherapeutics, Inc.
     IOVA
     8.00
     0.00%
   • NKTX
     Nkarta, Inc.
     NKTX
     5.34
     +1.33%
   • BBIO
     BridgeBio Pharma, Inc.
     BBIO
     27.15
     -1.67%
   • SANA
     Sana Biotechnology, Inc.
     SANA
     5.41
     -4.75%
   • APLS
     Apellis Pharmaceuticals, Inc.
     APLS
     39.56
     -1.29%

   More on Yahoo Finance

4. seekingalpha.com › article › 4685339-immunitybio-fdaImmunityBio: FDA Approval Gets Ball Rolling Towards Next Set ...

   seekingalpha.com › article › 4685339-immunitybio-fda

   Apr 23, 2024 · ImmunityBio, Inc. ( NASDAQ: IBRX) was able to receive FDA approval of its drug ANKTIVA plus Bacillus Calmette-Guerin [BCG] for the treatment of patients with BCG-unresponsive non-muscle invasive...

   • Author: Terry Chrisomalis

5. www.google.com › finance › quoteImmunitybio Inc (IBRX) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest Immunitybio Inc (IBRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

6. www.benzinga.com › quote › IBRXImmunityBio (NASDAQ:IBRX) Stock Quotes, Forecast and News ...

   www.benzinga.com › quote › IBRX

   • Cached

   6 days ago · The stock price for ImmunityBio (NASDAQ: IBRX) is $5.9401 last updated June 14, 2024 at 7:51 PM EDT.

   • Author: Benzinga
   • Day Range: 4.820-5.175

   • 52 Wk Range: 1.250-6.930
   • Open: $5.060

7. www.wallstreetzen.com › stocks › usImmunitybio Stock Price Today (NASDAQ: IBRX) Quote, Market ...

   www.wallstreetzen.com › stocks › us

   • Cached

   Jun 11, 2024 · IBRX Overview. ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers... read more.

8. seekingalpha.com › article › 4673686-immunitybioImmunityBio: Financial And Regulatory Risks Outweigh Anktiva ...

   seekingalpha.com › article › 4673686-immunitybio

   Feb 27, 2024 · ImmunityBio approaches Anktiva's PDUFA date, potentially entering a market led by Merck's Keytruda for NMIBC treatment. Learn why IBRX stock is a Sell.

9. www.morningstar.com › stocks › xnasIBRX Stock Price Quote | Morningstar

   www.morningstar.com › stocks › xnas

   • Cached

   6 days ago · See the latest ImmunityBio Inc Ordinary Shares stock price (IBRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.